216 related articles for article (PubMed ID: 26916712)
1. Characterizing the Association Between Alcohol and HIV Virologic Failure in a Military Cohort on Antiretroviral Therapy.
Deiss RG; Mesner O; Agan BK; Ganesan A; Okulicz JF; Bavaro M; Lalani T; O'Bryan TA; Bebu I; Macalino GE
Alcohol Clin Exp Res; 2016 Mar; 40(3):529-35. PubMed ID: 26916712
[TBL] [Abstract][Full Text] [Related]
2. Age, Race, and At-Risk Drinking in an HIV-infected U.S. Military Cohort.
Byrne M; Deiss R; Mesner O; Glancey M; Ganesan A; Okulicz J; Kronmann K; Maves R; Schofield C; Agan B; Macalino G
Mil Med; 2019 May; 184(5-6):e263-e267. PubMed ID: 30690493
[TBL] [Abstract][Full Text] [Related]
3. Alcohol use and immune reconstitution among HIV-infected patients on antiretroviral therapy in Nairobi, Kenya.
Cagle A; McGrath C; Richardson BA; Donovan D; Sakr S; Yatich N; Ngomoa R; Chepngeno Langat A; John-Stewart G; Chung MH
AIDS Care; 2017 Sep; 29(9):1192-1197. PubMed ID: 28132519
[TBL] [Abstract][Full Text] [Related]
4. Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: data from the ICONA cohort.
Saracino A; Lorenzini P; Lo Caputo S; Girardi E; Castelli F; Bonfanti P; Rusconi S; Caramello P; Abrescia N; Mussini C; Monno L; d'Arminio Monforte A;
Clin Microbiol Infect; 2016 Mar; 22(3):288.e1-8. PubMed ID: 26551839
[TBL] [Abstract][Full Text] [Related]
5. Risk of first-line antiretroviral therapy failure in HIV-infected Thai children and adolescents.
Bunupuradah T; Sricharoenchai S; Hansudewechakul R; Klinbuayaem V; Teeraananchai S; Wittawatmongkol O; Akarathum N; Prasithsirikul W; Ananworanich J;
Pediatr Infect Dis J; 2015 Mar; 34(3):e58-62. PubMed ID: 25478649
[TBL] [Abstract][Full Text] [Related]
6. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
7. Elevated CD8 counts during HAART are associated with HIV virologic treatment failure.
Krantz EM; Hullsiek KH; Okulicz JF; Weintrob AC; Agan BK; Crum-Cianflone NF; Ganesan A; Ferguson TM; Hale BR;
J Acquir Immune Defic Syndr; 2011 Aug; 57(5):396-403. PubMed ID: 21602694
[TBL] [Abstract][Full Text] [Related]
8. Alcohol consumption among HIV-infected women: impact on time to antiretroviral therapy and survival.
Neblett RC; Hutton HE; Lau B; McCaul ME; Moore RD; Chander G
J Womens Health (Larchmt); 2011 Feb; 20(2):279-86. PubMed ID: 21281111
[TBL] [Abstract][Full Text] [Related]
9. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
[TBL] [Abstract][Full Text] [Related]
10. Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors.
Corral I; Quereda C; Moreno A; Pérez-Elías MJ; Dronda F; Casado JL; Muriel A; Masjuán J; Alonso-de-Leciñana M; Moreno S
Cerebrovasc Dis; 2009; 27(6):559-63. PubMed ID: 19390181
[TBL] [Abstract][Full Text] [Related]
11. Virologic outcome and predictors of virologic failure of highly active antiretroviral therapy containing protease inhibitors.
Knobel H; Guelar A; Carmona A; Espona M; González A; López-Colomés JL; Saballs P; Gimeno JL; Díez A
AIDS Patient Care STDS; 2001 Apr; 15(4):193-9. PubMed ID: 11359661
[TBL] [Abstract][Full Text] [Related]
12. Bacterial pneumonia, HIV therapy, and disease progression among HIV-infected women in the HIV epidemiologic research (HER) study.
Kohli R; Lo Y; Homel P; Flanigan TP; Gardner LI; Howard AA; Rompalo AM; Moskaleva G; Schuman P; Schoenbaum EE;
Clin Infect Dis; 2006 Jul; 43(1):90-8. PubMed ID: 16758423
[TBL] [Abstract][Full Text] [Related]
13. Estimating the impact of alcohol consumption on survival for HIV+ individuals.
Braithwaite RS; Conigliaro J; Roberts MS; Shechter S; Schaefer A; McGinnis K; Rodriguez MC; Rabeneck L; Bryant K; Justice AC
AIDS Care; 2007 Apr; 19(4):459-66. PubMed ID: 17453583
[TBL] [Abstract][Full Text] [Related]
14. Alcohol consumption and antiretroviral adherence among HIV-infected persons with alcohol problems.
Samet JH; Horton NJ; Meli S; Freedberg KA; Palepu A
Alcohol Clin Exp Res; 2004 Apr; 28(4):572-7. PubMed ID: 15100608
[TBL] [Abstract][Full Text] [Related]
15. HIV treatment in drug abusers: impact of alcohol use.
Miguez MJ; Shor-Posner G; Morales G; Rodriguez A; Burbano X
Addict Biol; 2003 Mar; 8(1):33-7. PubMed ID: 12745413
[TBL] [Abstract][Full Text] [Related]
16. Individual variation in CD4 cell count trajectory among human immunodeficiency virus-infected men and women on long-term highly active antiretroviral therapy: an application using a Bayesian random change-point model.
Chu H; Gange SJ; Yamashita TE; Hoover DR; Chmiel JS; Margolick JB; Jacobson LP
Am J Epidemiol; 2005 Oct; 162(8):787-97. PubMed ID: 16135508
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcome of HIV-infected patients with sustained virologic response to antiretroviral therapy: long-term follow-up of a multicenter cohort.
Gutierrez F; Padilla S; Masiá M; Iribarren JA; Moreno S; Viciana P; Muñoz L; Gómez Sirvent JL; Vidal F; López-Aldeguer J; Blanco JR; Leal M; Rodríguez-Arenas MA; Perez Hoyos S;
PLoS One; 2006 Dec; 1(1):e89. PubMed ID: 17183720
[TBL] [Abstract][Full Text] [Related]
18. Current use of statins reduces risk of HIV rebound on suppressive HAART.
Drechsler H; Ayers C; Cutrell J; Maalouf N; Tebas P; Bedimo R
PLoS One; 2017; 12(3):e0172175. PubMed ID: 28249009
[TBL] [Abstract][Full Text] [Related]
19. Alcohol consumption patterns and HIV viral suppression among persons receiving HIV care in Florida: an observational study.
Cook RL; Zhou Z; Kelso-Chichetto NE; Janelle J; Morano JP; Somboonwit C; Carter W; Ibanez GE; Ennis N; Cook CL; Cohen RA; Brumback B; Bryant K
Addict Sci Clin Pract; 2017 Sep; 12(1):22. PubMed ID: 28950912
[TBL] [Abstract][Full Text] [Related]
20. Mortality in an urban cohort of HIV-infected and at-risk drug users in the era of highly active antiretroviral therapy.
Kohli R; Lo Y; Howard AA; Buono D; Floris-Moore M; Klein RS; Schoenbaum EE
Clin Infect Dis; 2005 Sep; 41(6):864-72. PubMed ID: 16107987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
